Lack of reactivity against the currently known neuronal antigens targeted in autoimmune mind disorders and the lack of similarity in…
A 20-fold molar more than dye was then put into the antibody solution as well as the blend was remaining…
Participants were divided into two groups, one for individuals previously infected with SARS-CoV-2 and the other for individuals without previous…
It was developed by PDL (Incline Village, NV, USA) and subsequently licensed to Biogen-Idec, Ophthotech (New York, NY, USA) and…
The overall survival rate was 20.2 months for patients with PD-L1 high-expressing tumors treated with atezolizumab compared to 13.1 months…